Quipt Home Medical Announces Filing of Form 40-F With SEC
May 14 2021 - 07:30AM
Quipt Home Medical Corp. (“
Quipt” or the
“
Company”) (TSXV:QIPT; OTCQX:PTQQD), a U.S. based
leader in the home medical equipment industry, focused on
end-to-end respiratory care, is pleased to announce that it has
filed a Form 40-F Registration Statement (“
Form
40-F”) with the United States Securities and Exchange
Commission (the “
SEC”), fulfilling a significant
milestone in the process for the Company to list its common shares
on The Nasdaq Capital Market (“
Nasdaq”). Quipt
will become a reporting issuer in the United States following
effectiveness of the Form 40-F, in addition to being a reporting
issuer in Canada. A copy of the Form 40-F is available on EDGAR,
SEDAR and the Company's website at www.protechhomemedical.com.
Listing of the Company’s common shares on Nasdaq
remains subject to the approval of Nasdaq and the satisfaction of
all applicable listing and regulatory requirements, including the
effectiveness of the Form 40-F. Following receipt of all required
approvals, the Company will issue a press release announcing its
first trading date on Nasdaq.
“Quipt’s rapidly growing operations are
completely based in the United States, making the filing of our
Form 40-F a significant steppingstone for the Company,” commented
Greg Crawford, CEO and Chairman of Quipt. “We are striving to
become a national leader in respiratory homecare in the United
States and are excited to utilize a Nasdaq listing to meaningfully
increase our Company’s awareness. With our robust balance sheet,
continued operating momentum, and pipeline of acquisitions, we are
excited to share our vision with a broader audience of
investors.”
In connection with the Company’s application for
listing on Nasdaq and filing of its Form 40-F, the Company’s
auditor has concluded its review of the Q1 Fiscal 2021 financial
statements for incorporation in the Form 40-F now filed with the
SEC. The amended and restated interim financial statements the
three months ended December 31, 2020 and 2019 and accompanying
Management Discussion & Analysis (MD&A) are available at
www.sedar.com. For additional clarification, please note there
has been no material change to the previously reported Q1 Fiscal
2021 financial statements.
ABOUT QUIPT HOME MEDICAL
CORP.
The Company provides in-home monitoring and
disease management services including end-to-end respiratory
solutions for patients in the United States healthcare market. It
seeks to continue to expand its offerings to include the management
of several chronic disease states focusing on patients with heart
or pulmonary disease, sleep disorders, reduced mobility and other
chronic health conditions. The primary business objective of the
Company is to create shareholder value by offering a broader range
of services to patients in need of in-home monitoring and chronic
disease management. The Company’s organic growth strategy is to
increase annual revenue per patient by offering multiple services
to the same patient, consolidating the patient’s services and
making life easier for the patient.
Forward-Looking Statements
Certain statements contained in this press
release constitute "forward-looking information" as such term is
defined in applicable Canadian securities legislation. The
words "may", "would", "could", "should", "potential", "will",
"seek", "intend", "plan", "anticipate", "believe", "estimate",
"expect" and similar expressions as they relate to the Company,
including: the acceptance of the Form 40-F filing with the SEC; and
the timing and completion of the proposed listing on Nasdaq; are
intended to identify forward-looking information. All statements
other than statements of historical fact may be forward-looking
information. Such statements reflect the Company's current views
and intentions with respect to future events, and current
information available to the Company, and are subject to certain
risks, uncertainties and assumptions, including: the Company
successfully identified, negotiating and completing additional
acquisitions, including accretive acquisitions. Many factors
could cause the actual results, performance or achievements that
may be expressed or implied by such forward-looking information
to vary from those described herein should one or more of these
risks or uncertainties materialize. Examples of such risk
factors include, without limitation: credit; market (including
equity, commodity, foreign exchange and interest rate);
liquidity; operational (including technology and infrastructure);
reputational; insurance; strategic; regulatory; legal;
environmental; capital adequacy; the general business and
economic conditions in the regions in which the Company
operates; the ability of the Company to execute on key
priorities, including the successful completion of acquisitions,
business retention, and strategic plans and to attract, develop
and retain key executives; difficulty integrating newly acquired
businesses; the ability to implement business strategies and
pursue business opportunities; low profit market segments;
disruptions in or attacks (including cyber-attacks) on the
Company's information technology, internet, network access or
other voice or data communications systems or services; the
evolution of various types of fraud or other criminal behavior
to which the Company is exposed; the failure of third parties to
comply with their obligations to the Company or its affiliates;
the impact of new and changes to, or application of, current laws
and regulations; decline of reimbursement rates; dependence on
few payors; possible new drug discoveries; a novel business model;
dependence on key suppliers; granting of permits and licenses
in a highly regulated business; the overall difficult
litigation environment, including in the U.S.; increased
competition; changes in foreign currency rates; increased
funding costs and market volatility due to market illiquidity
and competition for funding; the availability of funds and
resources to pursue operations; critical accounting estimates and
changes to accounting standards, policies, and methods used by
the Company; the occurrence of natural and unnatural catastrophic
events and claims resulting from such events; and risks
related to COVID-19 including various recommendations, orders and
measures of governmental authorities to try to limit the
pandemic, including travel restrictions, border closures,
non-essential business closures, quarantines,
self-isolations, shelters-in-place and social distancing,
disruptions to markets, economic activity, financing, supply
chains and sales channels, and a deterioration of general
economic conditions including a possible national or global
recession; as well as those risk factors discussed or referred
to in the Company’s disclosure documents filed with the
securities regulatory authorities in certain provinces of Canada
and available at www.sedar.com. Should any factor affect the
Company in an unexpected manner, or should assumptions
underlying the forward-looking information prove incorrect, the
actual results or events may differ materially from the
results or events predicted. Any such forward-looking information
is expressly qualified in its entirety by this cautionary
statement. Moreover, the Company does not assume responsibility
for the accuracy or completeness of such forward-looking
information. The forward-looking information included in this
press release is made as of the date of this press release and
the Company undertakes no obligation to publicly update or
revise any forward-looking information, other than as required by
applicable law.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
For further information please visit our website
at www.protechhomemedical.com, or contact:
Cole StevensVP of Corporate Development Quipt
Home Medical Corp.859-300-6455cole.stevens@myphm.com
Gregory CrawfordChief Executive OfficerQuipt
Home Medical Corp.859-300-6455investorinfo@myphm.com
Quipt Home Medical (TSXV:QIPT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Quipt Home Medical (TSXV:QIPT)
Historical Stock Chart
From Mar 2023 to Mar 2024